The latest research on using cutting-edge transcranial magnetic stimulation technology to treat patients with neurogenic speech, language and swallowing disorders will be showcased to more than 500 Australian speech pathologists later this month.
Neuroscientist Professor Bruce Murdoch will unveil the new approach, a non-invasive method designed to help people with Parkinson’s disease and post-stroke patients communicate, in his keynote presentation at Speech Pathology Australia’s 2012 national conference in Hobart, Tasmania, from June 24-27.
Professor Murdoch is the founder and director of the Centre for Neurogenic Communication Disorders Research at The University of Queensland, which is renowned world-wide for its research into physiological assessment and treatment of neurologically-based communication impairments.
Dr Murdoch’s presentation, including research and case examples, will be one of more than 130 presentations as part of the annual conference.
SPA national president Chris Stone said the conference would provide delegates with access to the latest research results and knowledge, which they could take back with them to their every-day practices.
“Speech Pathology Australia’s national conference is the profession’s annual opportunity to showcase the cutting-edge research and techniques that are being developed and pioneered in Australia,” Ms Stone said.
“We look forward to joining with speech pathologists from all around Australia to take part in speech pathology’s premier annual event.”
Other speakers include Dr Mabel Rice, who will provide an insight into the genetics of language impairment, and Dr Angela Morgan, whose research examines the neurobiological bases of childhood communication disorders and how they interact with environmental influences.
Follow Speech Pathology Australia and the 2012 national conference on Twitter here.